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Utility values for childhood obesity interventions: a systematic review and meta-analysis of the 
evidence for use in economic evaluation  
 
Abbreviations:  
CUA: cost-utility analysis.  QALY: quality-adjusted life year.  HRQoL: health-related quality of life.  
MAUIs: multi-attribute utility instruments.  PRISMA: Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses.  PROSPERO: International Prospective Register of Systematic Reviews. PEDE: 
Pediatric Economic Database Evaluation.  BMI: body mass index.  LFK: Luis Furuya-Kanamori.  WMD: 
weighted mean difference.  95% UI: 95% uncertainty interval.  CHEERS: Consolidated Health Economic 
Evaluation Reporting Standards.  AQoL-6D: Assessment of Quality of Life 6D.  CHU-9D: child health 
utility index 9D.  EQ-5D-Y: Euroqol 5D youth.  EQ-5D-3L: Euroqol 5D 3L.  HUI: health utilities index.  
UK: United Kingdom.  US: United States of America.  CEA: cost-effectiveness analysis.  PedsQL: 
Pediatric quality of life inventoryTM version 4.0 generic core scales.  
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Utility values for childhood obesity interventions: a systematic review and meta-analysis of the 
evidence for use in economic evaluation  
Abstract 
Rigorous estimates of preference-based utilities are important inputs into economic evaluations of 
childhood obesity interventions, yet no published review currently exists examining utility by weight 
status in paediatric populations. A comprehensive systematic literature review and meta-analysis was 
therefore undertaken, pooling data on preference-based health state utilities by weight status in children 
using a random effects model.  Tests for heterogeneity were performed and publication bias was 
assessed.  Of 3,434 potentially relevant studies identified, eleven met our eligibility criteria.  Estimates 
of Cohen’s d statistic suggested a small effect of weight status on preference-based utilities.  Mean 
utility values were estimated as 0.85 (95% UI 0.84-0.87), 0.83 (95% UI 0.81-0.85), 0.82 (95% UI 0.79-
0.84) and 0.83 (95% UI 0.80-0.86) for healthy weight, overweight, obese and overweight/obese states 
respectively.  Meta-analysis of studies reporting utility values for both healthy weight and 
overweight/obese participants found a statistically significant weighted mean difference (0.015, 95% UI 
0.003-0.026).  A small but statistically significant difference was also estimated between healthy weight 
and overweight participants (0.011, 95% UI 0.004-0.018).   Study findings suggest that paediatric 
specific benefits of obesity interventions may not be well reflected by available utility measures, 
potentially underestimating cost-effectiveness if weight loss in childhood/adolescence improves health 
or well-being.  
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1. Introduction 
Childhood overweight and obesity is a serious global public health challenge (1).  Given society’s scarce 
resources, rigorous economic evaluation of childhood obesity prevention and treatment interventions is 
a useful tool for priority-setting.  Cost-utility analysis (CUA) is a form of economic evaluation that 
compares the costs of an intervention with the benefits gained, incorporating intervention impact on 
both the quality and quantity of life.  CUA allows for comparison of cost-effectiveness across healthcare 
programs, and is used as a tool for allocating health resources by governments, including in Australia 
and the United Kingdom (2, 3). 
The quality adjusted life year (QALY) is the most widely used utility-based unit of measurement for CUA 
(4).  The use of QALYs allows for comparison between different health states or health outcomes within 
diverse populations (for example, both adult and child populations), with an underlying assumption that 
QALYs are of equal social value irrespective of who accrues them (5).  Preference-based health-related 
quality of life (HRQoL) is incorporated using health utilities that are indexed on a cardinal scale where 
0 represents death and 1 represents perfect health (6). Utilities are preference weights, with preference 
equated with value or desirability (7).  Utilities can be measured directly (using techniques such as 
Standard Gamble or Time Trade Off) or indirectly (using Multi-Attribute Utility Instruments (MAUIs))(8).  
The choice of utility method and measure can have an effect on estimated utility values, and in turn on 
cost-effectiveness results (9). 
Catalogues of utility values can help to inform the appropriate selection of values for use in economic 
modelling.    Health economists are often not equipped with the time or resources to elicit utility values 
either directly or indirectly themselves.  Reviews of utility values for use in adult populations across 
health states such as diabetes, cancer and mental disorders exist (9-13).  Evidence from such reviews 
improves the robustness, transparency and rigour of modelled economic evaluations, allowing for a 
more systematic approach to the selection of appropriate model parameters.  For example, the 
catalogue of weights by Tengs & Wallace (12) was used to inform the economic modelling of long-term 
health outcomes and economic consequences of intervention for diabetes mellitus (14).  The more 
recent study by Davies et al. (15) incorporated utility values from the review by Beaudet et al. (9) to 
investigate the cost-effectiveness of different therapies for patients with type 2 diabetes mellitus.   
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Limited reviews have examined utility values by weight status in adults (13, 16).  Measuring utilities for 
children and adolescents is however only an emerging field of research, given the complexities of 
valuation in these age groups (17).  In particular, whilst MAUIs have gained popularity as a 
straightforward and easy way to elicit values, most MAUIs have historically been applied in adult 
populations (18).  Limited catalogues or reviews of utility values in child or adolescent populations 
currently exist (19-22).  Additionally, no published reviews or catalogues of utility values for use in CUAs 
of childhood and adolescent obesity interventions have been identified. To date and to the best of our 
knowledge, studies undertaking meta-analysis of obesity-related HRQoL in paediatric populations have 
focused on non-preference based measures (23, 24).   
This study aims to systematically review studies reporting utility values by weight status in children and 
adolescents aged ≤18 years.  A meta-analysis was undertaken, providing a catalogue of utility values 
useful for informing CUAs of obesity interventions in paediatric populations.  In addition, this study 
reviews published economic evaluations of obesity interventions in paediatric populations that have 
measured or referenced utility-based HRQoL.  Health state utility values are often reported in economic 
evaluations, rather than solely in health benefit measurement studies (25).  This ensures an extensive 
scope for the search for utility values by weight status, and also provides an overview of the current 
state of practice and context for how published utility values are used in the economic modelling of 
paediatric obesity interventions.   
2. Methods 
The systematic review was based on the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines (26) and registered with PROSPERO (#CRD42017067226).  A search 
of the literature was conducted using key search strategies agreed in conjunction with a subject 
specialist librarian (Supporting information).  
To be considered for inclusion, studies had to meet the following criteria: 
 Studies published in peer-reviewed journals reporting primary data collection of utility values, 
with results reported by weight status; 
 Conducted in paediatric populations (mean or median target age ≤18 years); 
 Written in the English language; 
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 Published anytime until May 2017. 
Reviews or commentaries were excluded.  A search was also conducted for economic evaluations of 
obesity interventions published in peer-reviewed journals including an analysis of HRQoL that used or 
referenced a preference-based utility instrument.  Economic evaluations needed to include paediatric 
populations within their study population, but did not have to be limited to paediatric populations.  Utility 
values needed to specifically relate to weight status, rather than the potential health sequelae of obesity 
that can also appear in economic models that adopt long-term time horizons.  The Paediatric Economic 
Database Evaluation (PEDE) (27) was also searched, using the search terms “obes*”, “body mass 
index” and “BMI” as keyword/title/abstract search terms. Screening of potential study inclusions was 
conducted by two authors (VB, ET), with conflicts resolved in consultation with a third author (MM).  
Reference lists of all included studies were checked for further inclusions (i.e. backward citation 
searching).   
Data were extracted by one reviewer (VB) using Covidence (28) and Microsoft Excel, and checked by 
a second reviewer (ET).  Key characteristics of interest for studies eliciting utility values included study 
aim, methods, study population, sample size, intervention evaluated (where applicable), utility measure, 
tariff (where applicable), and QALY weights. Data on weight classification of the study population were 
extracted as per the BMI cutoff values used in each selected study.  Meta-analysis was undertaken with 
the Microsoft Excel add-in MetaXL version 5.3 (29) using a random effects model. Mean utility values 
for healthy weight, overweight, obese and overweight/obese (i.e. studies combining overweight and 
obese into a single category) states were estimated, ignoring potential within-study correlation in 
estimates because of the small numbers of studies included (30).  Utility values from relevant studies 
were included as separate observations in the meta-analyses. Forest plots were presented, and tests 
for heterogeneity were performed using I2 and Cochran’s Q test.  Heterogeneity was regarded as 
substantial when I2 exceeded 40% or the Q statistic was significant at p<0.10 (31).  Formal quality 
assessment of primary studies eliciting utility values was not undertaken, given a lack of standard 
systems or checklists for grading the quality of health state utility values (25, 32).  We examined 
potential publication and small study bias visually using funnel and Doi plots, where a symmetrical plot 
suggests no or little bias (33).  The Luis Furuya-Kanamori (LFK) index of asymmetry is also presented 
from the Doi plot, with an assessment of “no”, “minor” or “major” asymmetry (33).   
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Studies reporting mean utility values for both healthy weight and overweight/obese participants were 
also pooled to estimate the weighted mean difference (WMD) in utility values and 95% uncertainty 
interval (95% UI).  Sub-analyses were undertaken for studies reporting mean utility values for both 
healthy weight and either overweight or obese participants.  Cohen’s d effect sizes were estimated, 
where approximately 0.2, 0.5 and 0.8 are respectively considered small, moderate and large (34).   
A number of sensitivity analyses were undertaken to test the robustness of meta-analysis results.  
Firstly,  individual studies were sequentially excluded from all meta-analyses to gauge the effect on 
overall results (35) (Supporting information).  Variability in meta-analysis estimates may result from 
differences in the descriptive systems, valuation protocols and utility ranges of the utility measures.  
Therefore sensitivity analyses were also undertaken restricting study inclusion in the mean utility and 
WMD healthy weight and overweight/obese meta-analyses to (i) studies using the EQ-5D-Y (36, 37) 
and (ii) studies using the CHU-9D (37-39).  Sensitivity analyses for WMD between healthy weight and 
either overweight or obese states were only estimated for studies using the CHU-9D instrument (37-
39), due to the small number of included studies using other instruments.  Variability in meta-analysis 
results may also result from the use of different BMI cutoff reference values between studies 
(Supporting information).  Sensitivity analyses were therefore conducted, stratifying by BMI cutoff 
reference values.  Sensitivity analyses were also conducted to stratify study inclusions by age, by 
pooling studies whose mean study participant age was <10 years or ≥10 years. 
Key study variables of interest for economic evaluations of paediatric obesity interventions included 
those reported in the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 
checklist (40).  Economic evaluation studies were summarised narratively, focusing on methodology 
and use of preference-based utility values within the analyses. 
3. Results 
3.1 Selection and inclusion of studies 
After the removal of duplicates, the systematic search resulted in the identification of 3,434 potentially 
relevant publications (Figure 1).  Titles and abstracts were searched by two independent reviewers, 
following which 3,106 studies were excluded because they did not meet the inclusion criteria.  Full texts 
for the remaining 328 potentially relevant studies were located and searched, with 317 of these studies 
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excluded because they did not meet the inclusion criteria.  No additional papers were identified from 
the reference lists of included studies or the PEDE database.  A total of 11 studies were included in our 
review, nine health state valuation studies eliciting primary utility values (36-39, 41-45) and two 
economic evaluations (46, 47). 
 
Figure 1 – PRISMA flowchart of systematic review results 
 
3.2 Study characteristics- primary health state valuation studies eliciting utility values 
Health state valuation studies eliciting utility values were undertaken in Australia (38, 42, 43), England 
(36, 37, 39), the USA (41, 45) and the Netherlands (44).  All studies were cross-sectional, with seven 
studies reporting data collected at single time points within larger intervention studies (37-39, 42-45).  
Study settings included clinic or specialist care centres (41, 44), primary or middle schools (37, 39, 45), 
secondary schools (36, 42, 43) or a mix of both primary and secondary schools as part of a community-
based intervention (38).  The mean age of study participants varied between 6.3 years (39) and 15.7 
years (44) (Supporting information). Only one study used parental proxy report for utility (with self-report 
also undertaken in participants aged ≥8 years) (41).  
Utility instruments used are reported in Table 1.  As might be expected, the most common utility 
instruments were those developed specifically for use in children and adolescents, with the CHU-9D 
used in three studies (37-39) and the EQ-5D-Y used in two studies (36, 37).  One study (36) collected 
height and weight outcomes by self-report, with all other studies using objectively measured data.  
Studies used different weight classification BMI cutoff values (Supporting information), and weight 
classification categories varied between studies (healthy weight, overweight, obese, severe obesity, 
overweight/obese).  Only three included studies reported that utility data was non-normally distributed 
(38, 39, 41), with two studies specifically reporting the data as left-skewed (39, 41); only one study 
reported no underlying differences in the distribution of the utility data in different weight categories (39). 
Table 1 – Utility instruments from included studies 
 
Table 2 lists the published mean utility values by weight status from studies included in our review.  The 
study by Boyle et al. (36) invited participants to complete the study survey on two occasions (in winter 
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and in summer) but analysed the data cross-sectionally.  It is unclear how many of the children 
completed the survey at both time points.  Three studies used more than one utility instrument (37, 41, 
45); however, only the studies by Canaway & Frew 2014 (37) and Trevino et al. 2013 (45) reported 
complete results per instrument used. 
Table 2 – Published utility weights by weight status from the literature 
 
3.3 Results of meta-analyses 
Results from our systematic review demonstrate that there is a relatively wide range of utility values by 
weight status reported within the literature (range reported for healthy weight 0.73-0.93, overweight 
0.66-0.86, obese 0.69-0.84 and overweight/obese 0.67-0.89) (Table 2).  Figure 2 reports the forest plots 
for mean utility values by weight status.  The mean utility values were 0.85 (95% UI 0.84-0.87, I2=97, 
Q=424, p=0.00), 0.83 (95% UI 0.81-0.85, I2=89, Q=56.1, p=0.00), 0.82 (95% UI 0.79-0.84, I2=86, 
Q=42.1, p=0.00) and 0.83 (95% UI 0.8-0.86, I2=87, Q=55.5, p=0.00) for healthy weight, overweight, 
obese and overweight/obese states, respectively.  Given that only two studies reported utility values for 
the severe obesity weight category (40-41), a separate mean utility value for the severe obesity state 
was not estimated.  All meta-analyses displayed a moderate level of heterogeneity.   
Figure 2 – Forest plots of mean utility by weight status 
 
After pooling relevant results, the weighted mean difference in utility value between healthy weight and 
overweight/obese participants was small but statistically significant (WMD 0.015, 95% UI 0.003-0.026, 
I2=9.3, Q=7.7, p=0.36) (Table 2).  An even smaller but still statistically significant weighted mean 
difference in utility value was found between healthy weight and overweight participants (WMD 0.011, 
95% UI 0.004-0.018, I2=0, Q=1.6, p=0.95).  The WMD between healthy weight and obese participants 
was slightly larger; however, results suggest heterogeneity exists (0.024, 95% UI 0.009-0.039, I2=60.2, 
Q=15.1, p=0.02).  Visual inspection of funnel and Doi plots also indicated the possibility of publication 
bias for all analyses.  LFK Indexes for all analyses reported major asymmetry (Table 3). 
 
Table 3 – Pooled estimates of WMD in HRQoL in children and adolescents, by weight category  
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Sensitivity analyses were undertaken for all analyses and full results are presented in Supporting 
information files.  Omitting individual studies within the analyses of mean utility values for healthy 
weight, overweight, obese and overweight/obese states did not change results markedly. When 
considering all analyses, the mean utility value for healthy weight ranged from 0.82 (95% UI 0.78-0.87, 
when including only studies where the mean participant age was <10 years (37, 39)) to 0.88 (95% UI 
0.83-0.93, when including only studies using the EQ-5D-Y (36, 37)).  Mean utility values for the 
overweight/obese state ranged from 0.81 (95% UI 0.76-0.87, when only studies with a mean participant 
age <10 years were included (37, 39)) to 0.84 (95% UI 0.81-0.88, when only studies with a mean 
participant age ≥10 years were included (36, 38, 41, 42) or when individual studies were excluded from 
the analyses (37, 38, 41)). 
The sequential exclusion of the study by Bolton et al. (42) in the WMD analysis (healthy weight and 
overweight/obese), resulted in the WMD estimate no longer reaching statistical significance at the 5% 
level (WMD 0.014, 95% UI 0-0.029, I2=17, Q=7.3).  Restriction of inclusions in the analysis of WMD 
between healthy weight and overweight/obese to studies using the UK BMI cutoff reference values (60) 
resulted in the WMD estimate no longer reaching statistical significance at the 5% level (WMD 0.019, 
95% UI -0.004-0.043, I2=43, Q=7).  Restrictions of inclusions into the analysis of WMD between healthy 
weight and overweight/obese to studies using either the EQ-5D-Y (36, 37) or the CHU-9D (37-39) 
resulted in WMD in health utility no longer reaching statistical significance (Supporting information), 
although it should be noted that these analyses were limited by the small number of study inclusions by 
instrument.  Similar findings resulted from restricting inclusions into healthy weight and either 
overweight or obese analyses to those studies using the CHU9D (healthy weight and overweight: WMD 
0.011, 95% UI -0.001-0.022, I2=0, Q=0.07; healthy weight and obese: WMD 0.019, 95% UI -0.014-
0.051, I2=61, Q=5.1)(Supporting information).   
3.4 Summary of economic evaluations 
Only two economic evaluations of obesity interventions were identified as including an analysis of 
weight-related HRQoL using or referencing a utility-based instrument (Supporting information).  The 
study by McAuley et al. (46) evaluated a community-based obesity prevention intervention and utilised 
the Health Utilities Index (HUI) to collect parental proxy HRQoL data for a sample of New Zealand 
children aged 5 to 12 years.  No statistically significant differences between the intervention and control 
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groups were reported, and utility by weight status was therefore not reported.  The economic evaluation 
consisted of a cost-effectiveness analysis (CEA), where results were presented as cost per kilogram of 
weight gain prevented from the intervention. 
The study by Robertson et al. (47) evaluated the effectiveness and cost-effectiveness of a community-
based programmatic intervention.  Data on utility values were collected at baseline, three and twelve 
months using the EQ-5D-Y based on both child self-report and parental proxy.  Although utility values 
were not specifically reported, a statistically significant change in HRQoL was not found in study 
participants between intervention timepoints.  Among children with complete cost and QALY data over 
the study period, the intervention was associated with a mean incremental QALY gained of only 0.0009. 
4. Discussion 
Many of the conditions for which obesity is a risk factor, such as stroke, heart disease and type 2 
diabetes, generally occur later in life (61, 62).  HRQoL may therefore be the most measurable impact 
of overweight and obesity in the childhood years, and this is an important consideration when 
undertaking CUA of obesity interventions in paediatric populations.  Given the potential influence on 
cost-effectiveness results, the selection of appropriate health state utility values is important.  Therefore 
estimates of utility associated with weight status arising from meta-analyses are useful in improving the 
rigour and reliability of CUA findings, as well as providing an overview of the current state of evidence 
for the impact of overweight and obesity on preference-based HRQoL in children and adolescents.   
Studies in adult populations have estimated lower utility-based HRQoL between healthy weight and 
overweight or obese states (63).  For instance, the study by Sach et al. (64) estimated a statistically 
significant mean difference of -0.099 between healthy weight and obese class I states using the EQ-5D 
instrument.  A broad systematic review and meta-analysis of childhood health utilities by Kwon et al. 
has very recently been published (22).  However, the breadth of that review did not allow the authors 
to focus on weight status in children in the granulated way that we do. For example, Kwon et al. (22) 
estimate weighted averages of mean utility or VAS scores for broad ICD-10 delineated categories that 
grouped obese status and type II diabetes together. Moreover, Kwon et al. do not estimate utility score 
differences between children categorised as either healthy weight, overweight, obese and 
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overweight/obese (22). Our review therefore presents a more in-depth and granulated assessment of 
utility values by weight status in children and adolescents aged ≤18 years.   
Our systematic review demonstrated that the current literature on utility values for children and 
adolescents by weight status is limited.  There is also a relatively wide range of values estimated.  The 
results of our meta-analyses displayed high degrees of heterogeneity; however, pooled analyses 
suggest that in children and adolescents, overweight and obesity states are associated with lower utility 
values than those for a healthy weight.  This is important information for health economists and those 
interested in priority setting, with the catalogue of preference-based utility values presented here useful 
as inputs into economic evaluations of obesity interventions in paediatric populations.  Whilst we do not 
recommend these values as definitive given the limited evidence base, our results highlight the potential 
for impact of interventions that are effective at changing weight status through the childhood years.  
Utility measurement in childhood populations is clearly an underexplored area, with more research 
required to better understand the clinical importance and significance of HRQoL in children and 
adolescents.  We found only 11 relevant studies for our review, although several other studies 
measured utility values, but were not included in our analyses because they did not report scored utility 
values (65-68) or ascribe them to weight categories (69).  Reviews of non-preference based studies 
assessing HRQoL in childhood populations suggest poorer HRQoL in obese youth (24, 70-72), with 
recent studies finding that interventions that reduce BMI are associated with improvements in HRQoL 
(73, 74).  Our meta-analysis results broadly support these findings, however given this is a relatively 
emerging field within the literature, it is clear that more research is required to better understand 
potential quantitative associations useful for economic modelling.  Our meta-analysis results are also 
broadly consistent with the findings of other studies reporting an element of ill-health or suboptimal 
HRQoL in the general population (75).  Our estimated utility value for healthy weight children (mean 
0.85 (95% UI 0.84-0.87)) is consistent with the findings from Kwon et al. (22), who reported a mean 
utility using the HUI3 of 0.876 (95% UI 0.788-0.965). 
A hypothesis within the literature is that very young children do not experience any loss of HRQoL due 
to weight status, but that older children and adolescents may (37).  We identified only two studies 
estimating utilities for children under 10 years (37, 39), and so our sensitivity analyses estimating mean 
utilities in younger populations were limited by the lack of study inclusions.  Results demonstrated 
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overlapping of confidence intervals in utility values between younger children (i.e. <10 years) of healthy 
weight (0.82 (95% UI 0.78-0.87)) and those that were overweight/obese (0.81 (95% UI 0.76-0.87)).  
Whilst this may suggest either no or minimal effect of weight status on HRQoL in younger children, it is 
clear that more research is required for a better understanding of the potential differential effects across 
the childhood and adolescent years.  This is important because if the HRQoL decrements between 
weight states are small, interventions aimed at reducing obesity in children are only likely to be cost-
effective based on QALYs if they are either very low cost or if the intervention effects are able to be 
sustained through to adulthood, thereby reducing the incidence of chronic diseases in later life.  Debate 
exists within the literature on the appropriateness of using QALY outcome measures in cost-utility 
analysis for children, rather than cost-effectiveness analysis where benefits are expressed in terms of 
natural units (for example, cost per BMI unit saved)(76). 
Many studies conducted in paediatric populations use non-preference based measures such as the 
Paediatric Quality of Life InventoryTM Version 4.0 Generic Core Scales (PedsQLTM)(77).  Non-
preference based measures can be mapped or cross-walked onto generic preference-based measures 
of health; however, there are current limitations in doing so in paediatric populations (20, 78).  The 
current state of the literature allows for mapping from the PedsQL to the CHU9D in adolescents (78) or 
to the EQ-5D-Y in children aged 11-15 years (79).  More research is required to extend these and other 
mapping algorithms across different populations and age groups.   
Measuring child and adolescent HRQoL is challenging, and there are well-recognised limitations to 
existing methods (17).  Accurately capturing information on HRQoL in children requires instruments that 
are sensitive to detect differences and appropriate to deliver across different age groups.  For instance, 
whilst younger children in particular may require parental proxy reporting, the accuracy of such reporting 
has recently been questioned with Ul-Haq et al. (24) finding that parents may overestimate the impact 
of obesity on the HRQoL of their children.  In addition, the tariffs for scoring utility values for many 
instruments may not necessarily reflect the values of childhood or adolescent populations if elicited from 
general populations. 
The findings of our systematic review and meta-analysis highlight that HRQoL is a significant source of 
uncertainty in the economic modelling of obesity interventions in childhood populations.  The current 
paucity of published utility values by weight status is reflected in the lack of published cost-utility 
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analyses of paediatric obesity interventions incorporating HRQoL in childhood.  Many cost-
effectiveness analyses of paediatric obesity interventions focus on averting adult obesity, and only 
include utility values to estimate QALYs in adults (for example, (80, 81)).  This may not allow for the 
HRQoL benefits of an intervention during childhood to be considered (41), and may underestimate 
intervention cost-effectiveness if overweight or obese states themselves have a significant impact on 
HRQoL in childhood and adolescence.  The recent study by Lal et al. (82) was published after our 
literature search was completed, but modelled the cost-effectiveness of a sugar-sweetened beverage 
tax across socioeconomic position using utility values for healthy weight and obesity in children and 
adolescents sourced from Chen et al. (38).  This may reflect the growing interest in trying to capture the 
full range of costs and benefits of obesity interventions in childhood and adolescence, particularly when 
disease-specific consequences are largely experienced later in life. 
The strengths of our study include the comprehensive and systematic search strategies, as well as the 
undertaking of a number of sensitivity analyses.  This allowed for a range of summary estimates to be 
produced, for inclusion within economic evaluations at the discretion of study authors given the relative 
uncertainty within the body of literature. 
Our study has some limitations, which should be borne in mind by readers.  The small number of studies 
included in our meta-analyses means that less confidence may be placed in results, although we 
present all values here as a quantitative summary of the literature as it currently stands and recommend 
use with caution.  The published evidence on which we have based our results has also only been 
undertaken in Western developed countries, and therefore the generalisability of these results to 
countries with differing cultural associations around body weight is unknown. Whilst our results build 
upon the currently limited evidence base on the impact of HRQoL by weight status in paediatric 
populations, it is clear that further investigation is required.  
We also did not conduct quality assessments of studies included in our meta-analyses, and therefore 
cannot comment on the rigour or reliability of study inclusions.  The lack of standard systems or 
validated checklists for grading the quality of health state utility values for inclusion in meta-analysis is 
both a limitation and an area for future research (32, 83).  Due to the small number of study inclusions 
and the lack of a validated quality assessment tool, we assumed that the quality across all included 
studies was of an equal standard, and this may in fact not have been the case.  This in turn may 
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influence results of the meta-analyses, however we have tried to circumvent this through extensive 
sensitivity analyses omitting individual studies from the analyses in order to gauge overall effects on 
utility estimates.  It is also possible that publication bias may influence these results, with studies finding 
no statistically significant difference in preference-based utility perhaps less likely to be published than 
studies that report a difference, and this should be considered.  
Results have also been pooled across studies using different utility instruments, BMI cutoff values and 
tariffs for scoring, in different study populations. The use of meta-analytical methods to pool utility values 
from different instruments is an ongoing area for investigation, with more research required into the 
sources of variation in utility values that may be driven by differences in descriptive systems (84).  We 
have again attempted to circumvent this by undertaking several sensitivity analyses, although the low 
number of studies using each respective instrument or by age group was a limitation. Finally, our 
systematic review and meta-analysis identified only cross-sectional studies examining HRQoL by 
weight status.  It is possible that reverse causation may be a factor in any association, and given the 
current evidence base we are unable to establish whether BMI might impact on the HRQoL of children 
and adolescents or vice versa.  More rigorous investigation is therefore required, exploring causation 
and the complexity of possible associations through multiple pathways.   
5. Conclusion 
This study represents the first systematic review and meta-analysis of utility values by weight status for 
childhood populations, demonstrating the relative lack of published preference-based utility values by 
weight status in paediatric populations.  To date, very few economic evaluations of obesity interventions 
incorporating HRQoL benefits to children and adolescents have been published.  This potentially results 
in under-estimation of the cost-effectiveness of obesity interventions in children and adolescents. Meta-
analysis results provide mean utility values by healthy weight, overweight, obese and overweight/obese 
states, although results should be interpreted with caution given high degrees of heterogeneity.  Results 
demonstrate higher preference-based utility values in healthy weight as compared to overweight or 
obese children and adolescents, but more evidence is required to improve the rigour and reliability of 
these estimates. 
Figure 1 – PRISMA flowchart of systematic review results 
Table 1 – Utility instruments from included studies 
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Table 2 – Published utility weights by weight status from the literature 
Figure 2 – Forest plots of mean utility by weight status 
Table 3 – Pooled estimates of WMD in HRQoL in children and adolescents, by weight category  
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